Elizabeth Widmer
Medical · Fort Worth, TXNPI 1336562883
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,216 of the $14,248 with a category attached, or 85.7%. It is spread thinly across 33 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 641 payments — averaging $22.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Dermavant Sciences, Inc.$2K
- Journey Medical Corporation$1K
- Arcutis Biotherapeutics, Inc.$1K
- Galderma Laboratories, L.p.$900
- Mayne Pharma Commercial LLC$872
- plus $6K from 27 others
What the payments were for
- Consulting fees$2,02514%
- Food & beverage$12,21686%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 87 | $1,992 |
| Dermavant Sciences, Inc. | 53 | $1,778 |
| Journey Medical Corporation | 11 | $1,440 |
| Arcutis Biotherapeutics, Inc. | 95 | $1,186 |
| Galderma Laboratories, L.p. | 57 | $900 |
| Mayne Pharma Commercial LLC | 63 | $872 |
| Sun Pharmaceutical Industries Inc. | 43 | $858 |
| Incyte Corporation | 29 | $835 |
| Sanofi | 23 | $606 |
| Novartis | 25 | $501 |
| Pfizer | 31 | $469 |
| Regeneron Healthcare Solutions, Inc. | 18 | $400 |
| Lilly USA, LLC | 16 | $356 |
| UCB, Inc. | 8 | $348 |
| LEO Pharma Inc. | 14 | $261 |
| VYNE Pharmaceuticals Inc. | 7 | $245 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 14 | $224 |
| E.r. Squibb & Sons, L.L.C. | 5 | $192 |
| Organon | 8 | $147 |
| Amgen | 6 | $137 |
| Medimetriks Pharmaceuticals, Inc. | 5 | $103 |
| Johnson & Johnson | 5 | $88 |
| Almirall LLC | 3 | $47 |
| Dermira, Inc. | 3 | $47 |
| Boehringer Ingelheim | 2 | $42 |
| Genentech USA, Inc. | 2 | $40 |
| Misonix Inc | 2 | $25 |
| Merz North America, Inc. | 1 | $24 |
| Cipher Pharmaceuticals US LLC | 1 | $19 |
| Biofrontera Inc. | 1 | $18 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Botanix SB Inc | 1 | $15 |
| Boston Scientific | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,248 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 44 | $169,838 |
| Dupixent SyringeDupilumab | 11 | $40,915 |
| Tacrolimus | 11 | $2,681 |
| Fluorouracil | 26 | $2,022 |
| Triamcinolone Acetonide | 92 | $1,901 |
| Minocycline Hcl | 39 | $878 |
| Fluocinolone Acetonide | 17 | $778 |
| Betamethasone Dipropionate | 17 | $684 |
| Clobetasol Propionate | 21 | $625 |
| Ondansetron OdtOndansetron | 13 | $465 |
| Minoxidil | 27 | $370 |
| Spironolactone | 11 | $164 |
| Mupirocin | 16 | $115 |
Paid to pharmacies, not to this prescriber.
Other medical in Fort Worth
- Mark DavisFort Worth$1M
- Francesca FongFort Worth$25K
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.